Immunogenicity and Safety of a Full-Dose Regimen of Cell Culture-Derived Quadrivalent Inactivated Influenza Vaccine in Children Aged 6-35 Months: Results from a Multinational Phase 3 Randomised Controlled Trial. - Yoon Y; Cho HK; Kim KH; Park SE; Kim YJ; Lee J; Kim HM; Kim NH; Jo DS; Cho EY; Shin SH; Kim JH; et al. (Vaccines, 2026)